← Back to Search

Nicotine Replacement Therapy

Nicotine patch for Quitting Smoking

Phase 4
Waitlist Available
Led By Cunningham John, PhD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month follow-up
Awards & highlights

Study Summary

This study is evaluating whether a program of nicotine patches can help people quit smoking in rural areas.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
30-day point prevalence abstinence

Side effects data

From 2020 Phase 4 trial • 1251 Patients • NCT03176784
30%
Nausea
30%
Insomnia
17%
Skin Rash
16%
Changes in Mood
13%
Itching/Hives
4%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Varenicline + Patch Standard Duration
Varenicline + Patch Extended Duration
Varenicline Only Standard Duration
Varenicline Only Extended Duration

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nicotine Replacement TherapyExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine patch
2015
Completed Phase 4
~7450

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
356 Previous Clinical Trials
80,946 Total Patients Enrolled
Cunningham John, PhDPrincipal InvestigatorCentre for Addiction and Mental Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~115 spots leftby Apr 2025